• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED - Announcements

0.00% ! 0.3¢
Market Cap $9.747M  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



CHM Reinstatement to Official QuotationPRICE SENSITIVE21/10/24 download Created with Sketch. 413.35KB
CHM ESG Report21/10/24 download Created with Sketch. 1.01MB
CHM Corporate Governance Statement and Appendix 4G21/10/24 download Created with Sketch. 447.66KB
CHM Annual Report 202421/10/24 download Created with Sketch. 2.17MB
CHM Proposed issue of securities - CHM21/10/24 download Created with Sketch. 21.66KB
CHM Proposed issue of securities - CHM21/10/24 download Created with Sketch. 15.3KB
CHM $5 million Placement to progress CHM CDH17 trialPRICE SENSITIVE21/10/24 download Created with Sketch. 228.27KB
CHM Change in substantial holding - PH16/10/24 download Created with Sketch. 350.52KB
CHM Notice of Annual General Meeting14/10/24 download Created with Sketch. 614.21KB
CHM 2024 Annual Report update11/10/24 download Created with Sketch. 168.79KB
CHM AML patient achieves Complete Response in CHM CORE-NK trialPRICE SENSITIVE07/10/24 download Created with Sketch. 300.81KB
CHM 2024 Annual Report update04/10/24 download Created with Sketch. 163.29KB
CHM Suspension from QuotationPRICE SENSITIVE01/10/24 download Created with Sketch. 428.71KB
CHM Achieve Clinics collaboration to expand reach of CHM CDH1725/09/24 download Created with Sketch. 212.94KB
CHM Notice under section 708A20/09/24 download Created with Sketch. 206.21KB
CHM Application for quotation of securities - CHM20/09/24 download Created with Sketch. 15.77KB
CHM University of Pennsylvania joins CHM CDH17 Phase 1/2 trial11/09/24 download Created with Sketch. 200.32KB
CHM Notice under section 708A30/08/24 download Created with Sketch. 206.95KB
CHM Notification regarding unquoted securities - CHM30/08/24 download Created with Sketch. 16.53KB
CHM Application for quotation of securities - CHM30/08/24 download Created with Sketch. 20.92KB
CHM Appendix 4E and Preliminary Final ReportPRICE SENSITIVE30/08/24 download Created with Sketch. 1.01MB
CHM First patient dosed in Phase 1/2 trial of CHM CDH17PRICE SENSITIVE28/08/24 download Created with Sketch. 199.52KB
CHM Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete16/08/24 download Created with Sketch. 199.1KB
CHM Chimeric receives $1.5 M advance on FY24 R&D tax incentive13/08/24 download Created with Sketch. 192.88KB
CHM Chimeric partnering with Cell Therapies Australia09/08/24 download Created with Sketch. 194.27KB
CHM Notice under section 708A02/08/24 download Created with Sketch. 202.95KB
CHM Application for quotation of securities - CHM02/08/24 download Created with Sketch. 15.76KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/24 download Created with Sketch. 891.2KB
CHM Investor Presentation25/07/24 download Created with Sketch. 4.91MB
CHM First patient enrolled in CHM CDH17 Phase 1/2 clinical trialPRICE SENSITIVE22/07/24 download Created with Sketch. 179.3KB
CHM Notice under section 708A28/06/24 download Created with Sketch. 202.44KB
CHM Application for quotation of securities - CHM28/06/24 download Created with Sketch. 15.76KB
CHM Notification of cessation of securities - CHM26/06/24 download Created with Sketch. 13.33KB
CHM Results of Meeting11/06/24 download Created with Sketch. 235.37KB
CHM Presentation to Extraordinary General Meeting11/06/24 download Created with Sketch. 1.28MB
CHM Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDAPRICE SENSITIVE05/06/24 download Created with Sketch. 194.75KB
CHM Final Director's Interest Notice30/05/24 download Created with Sketch. 234.46KB
CHM Notice under section 708A30/05/24 download Created with Sketch. 203.14KB
CHM Application for quotation of securities - CHM30/05/24 download Created with Sketch. 15.92KB
CHM Chimeric opens CHM CDH17 Phase 1/2 trialPRICE SENSITIVE22/05/24 download Created with Sketch. 196.15KB
CHM CHM CDH17 Phase 1/2 clinical trial approved for initiationPRICE SENSITIVE20/05/24 download Created with Sketch. 170.63KB
CHM CHM CORE-NK vactosertib Phase 1b study re-opens enrolment16/05/24 download Created with Sketch. 192.2KB
CHM Notification regarding unquoted securities - CHM13/05/24 download Created with Sketch. 16KB
CHM Notice of Extraordinary General Meeting/Proxy Form13/05/24 download Created with Sketch. 488.24KB
CHM Notice under section 708A02/05/24 download Created with Sketch. 202.5KB
CHM Application for quotation of securities - CHM02/05/24 download Created with Sketch. 15.76KB
CHM Dr Rebecca McQualter appointed COO02/05/24 download Created with Sketch. 224.64KB
CHM Resignation of CEO and Managing DirectorPRICE SENSITIVE01/05/24 download Created with Sketch. 170.33KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 1.55MB
CHM Change of Director's Interest Notice PH08/04/24 download Created with Sketch. 170.14KB
CHM Change of Director's Interest Notice PH08/04/24 download Created with Sketch. 211.99KB
CHM US patent allowed for CHM 0201 (CORE-NK) technology05/04/24 download Created with Sketch. 172.62KB
CHM Notification of cessation of securities - CHM02/04/24 download Created with Sketch. 12.78KB
CHM Notice under section 708A28/03/24 download Created with Sketch. 202.53KB
CHM Application for quotation of securities - CHM28/03/24 download Created with Sketch. 15.8KB
CHM Chimeric to present at NWR Virtual Healthcare Conference15/03/24 download Created with Sketch. 171.83KB
CHM Clinical milestones for 2024 & 2023 successes highlightedPRICE SENSITIVE14/03/24 download Created with Sketch. 267.67KB
CHM Notification of cessation of securities - CHM07/03/24 download Created with Sketch. 13.49KB
CHM Notice under section 708A29/02/24 download Created with Sketch. 203.08KB
CHM Half Yearly Report and AccountsPRICE SENSITIVE29/02/24 download Created with Sketch. 1.87MB
CHM Application for quotation of securities - CHM28/02/24 download Created with Sketch. 15.79KB
CHM Chimeric to present at ShareCafe Hidden Gems webinar28/02/24 download Created with Sketch. 171.46KB
CHM Late lodgement of Appendix 3Y15/02/24 download Created with Sketch. 333.3KB
CHM 1st patient treated in ADVENT-AML Phase 1b clinical trialPRICE SENSITIVE08/02/24 download Created with Sketch. 196.21KB
CHM Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 297.36KB
CHM Application for quotation of securities - CHM24/01/24 download Created with Sketch. 24.77KB
CHM Investor Presentation18/01/24 download Created with Sketch. 8.75MB
CHM Placement of Entitlement Offer ShortfallPRICE SENSITIVE18/01/24 download Created with Sketch. 200.57KB
CHM ADVENT-AML Phase 1B clinical trial open to enrolmentPRICE SENSITIVE15/01/24 download Created with Sketch. 197KB
CHM CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVEPRICE SENSITIVE10/01/24 download Created with Sketch. 172.69KB
CHM Notice Under Section 708A05/01/24 download Created with Sketch. 202.47KB
CHM Notification regarding unquoted securities - CHM05/01/24 download Created with Sketch. 26.24KB
CHM Application for quotation of securities - CHM05/01/24 download Created with Sketch. 25.43KB
CHM Proposed issue of securities - CHM04/01/24 download Created with Sketch. 24.39KB
CHM Proposed issue of securities - CHM04/01/24 download Created with Sketch. 24.44KB
CHM CHM Secures Further $1M Investment04/01/24 download Created with Sketch. 196.74KB
CHM Notice under section 708A22/12/23 download Created with Sketch. 202.39KB
CHM Application for quotation of securities - CHM22/12/23 download Created with Sketch. 25.02KB
CHM Notification regarding unquoted securities - CHM22/12/23 download Created with Sketch. 23.71KB
CHM Chimeric to present at Biotech Showcase at JPM week21/12/23 download Created with Sketch. 172.96KB
CHM ADVENT-AML clinical trial GMP manufacturing complete19/12/23 download Created with Sketch. 197.85KB
CHM Notice under section 708A15/12/23 download Created with Sketch. 202.34KB
CHM Change of Director's Interest Notice JC15/12/23 download Created with Sketch. 238.57KB
CHM Notification of cessation of securities - CHM15/12/23 download Created with Sketch. 22.2KB
CHM Notification regarding unquoted securities - CHM15/12/23 download Created with Sketch. 26.63KB
CHM Notification regarding unquoted securities - CHM15/12/23 download Created with Sketch. 27.35KB
CHM Application for quotation of securities - CHM15/12/23 download Created with Sketch. 33.85KB
CHM Change of Director's Interest Notice PHa14/12/23 download Created with Sketch. 185.13KB
CHM Application for quotation of securities - CHM07/12/23 download Created with Sketch. 24.93KB
CHM Completion of Entitlement OfferPRICE SENSITIVE07/12/23 download Created with Sketch. 167.31KB
CHM Positive in vitro data for CHM 1301 CAR NK cells-supplement28/11/23 download Created with Sketch. 223.63KB
CHM Program update webinar with executive team - Tuesday 28 Nov24/11/23 download Created with Sketch. 208.4KB
CHM Positive in vitro data for CHM 1301 CAR NK cellsPRICE SENSITIVE23/11/23 download Created with Sketch. 217.9KB
CHM Amended Constitution22/11/23 download Created with Sketch. 573.94KB
CHM Phase 1B ADVENT-AML trial to be presented at ASH meeting20/11/23 download Created with Sketch. 219.57KB
CHM Update - Proposed issue of securities - CHM15/11/23 download Created with Sketch. 28.27KB
CHM Entitlement Offer closing date extended to 30 November 202315/11/23 download Created with Sketch. 193.75KB
CHM Results of Annual General Meeting14/11/23 download Created with Sketch. 228.67KB
CHM Presentation to Annual General Meeting14/11/23 download Created with Sketch. 1.72MB
CHM Notice under section 708A03/11/23 download Created with Sketch. 202KB
CHM Reinstatement to Official Quotation
21/10/24PRICE SENSITIVE download Created with Sketch. 413.35KB
CHM ESG Report
21/10/24 download Created with Sketch. 1.01MB
CHM Corporate Governance Statement and Appendix 4G
21/10/24 download Created with Sketch. 447.66KB
CHM Annual Report 2024
21/10/24 download Created with Sketch. 2.17MB
CHM Proposed issue of securities - CHM
21/10/24 download Created with Sketch. 21.66KB
CHM Proposed issue of securities - CHM
21/10/24 download Created with Sketch. 15.3KB
CHM $5 million Placement to progress CHM CDH17 trial
21/10/24PRICE SENSITIVE download Created with Sketch. 228.27KB
CHM Change in substantial holding - PH
16/10/24 download Created with Sketch. 350.52KB
CHM Notice of Annual General Meeting
14/10/24 download Created with Sketch. 614.21KB
CHM 2024 Annual Report update
11/10/24 download Created with Sketch. 168.79KB
CHM AML patient achieves Complete Response in CHM CORE-NK trial
07/10/24PRICE SENSITIVE download Created with Sketch. 300.81KB
CHM 2024 Annual Report update
04/10/24 download Created with Sketch. 163.29KB
CHM Suspension from Quotation
01/10/24PRICE SENSITIVE download Created with Sketch. 428.71KB
CHM Achieve Clinics collaboration to expand reach of CHM CDH17
25/09/24 download Created with Sketch. 212.94KB
CHM Notice under section 708A
20/09/24 download Created with Sketch. 206.21KB
CHM Application for quotation of securities - CHM
20/09/24 download Created with Sketch. 15.77KB
CHM University of Pennsylvania joins CHM CDH17 Phase 1/2 trial
11/09/24 download Created with Sketch. 200.32KB
CHM Notice under section 708A
30/08/24 download Created with Sketch. 206.95KB
CHM Notification regarding unquoted securities - CHM
30/08/24 download Created with Sketch. 16.53KB
CHM Application for quotation of securities - CHM
30/08/24 download Created with Sketch. 20.92KB
CHM Appendix 4E and Preliminary Final Report
30/08/24PRICE SENSITIVE download Created with Sketch. 1.01MB
CHM First patient dosed in Phase 1/2 trial of CHM CDH17
28/08/24PRICE SENSITIVE download Created with Sketch. 199.52KB
CHM Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete
16/08/24 download Created with Sketch. 199.1KB
CHM Chimeric receives $1.5 M advance on FY24 R&D tax incentive
13/08/24 download Created with Sketch. 192.88KB
CHM Chimeric partnering with Cell Therapies Australia
09/08/24 download Created with Sketch. 194.27KB
CHM Notice under section 708A
02/08/24 download Created with Sketch. 202.95KB
CHM Application for quotation of securities - CHM
02/08/24 download Created with Sketch. 15.76KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24PRICE SENSITIVE download Created with Sketch. 891.2KB
CHM Investor Presentation
25/07/24 download Created with Sketch. 4.91MB
CHM First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
22/07/24PRICE SENSITIVE download Created with Sketch. 179.3KB
CHM Notice under section 708A
28/06/24 download Created with Sketch. 202.44KB
CHM Application for quotation of securities - CHM
28/06/24 download Created with Sketch. 15.76KB
CHM Notification of cessation of securities - CHM
26/06/24 download Created with Sketch. 13.33KB
CHM Results of Meeting
11/06/24 download Created with Sketch. 235.37KB
CHM Presentation to Extraordinary General Meeting
11/06/24 download Created with Sketch. 1.28MB
CHM Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA
05/06/24PRICE SENSITIVE download Created with Sketch. 194.75KB
CHM Final Director's Interest Notice
30/05/24 download Created with Sketch. 234.46KB
CHM Notice under section 708A
30/05/24 download Created with Sketch. 203.14KB
CHM Application for quotation of securities - CHM
30/05/24 download Created with Sketch. 15.92KB
CHM Chimeric opens CHM CDH17 Phase 1/2 trial
22/05/24PRICE SENSITIVE download Created with Sketch. 196.15KB
CHM CHM CDH17 Phase 1/2 clinical trial approved for initiation
20/05/24PRICE SENSITIVE download Created with Sketch. 170.63KB
CHM CHM CORE-NK vactosertib Phase 1b study re-opens enrolment
16/05/24 download Created with Sketch. 192.2KB
CHM Notification regarding unquoted securities - CHM
13/05/24 download Created with Sketch. 16KB
CHM Notice of Extraordinary General Meeting/Proxy Form
13/05/24 download Created with Sketch. 488.24KB
CHM Notice under section 708A
02/05/24 download Created with Sketch. 202.5KB
CHM Application for quotation of securities - CHM
02/05/24 download Created with Sketch. 15.76KB
CHM Dr Rebecca McQualter appointed COO
02/05/24 download Created with Sketch. 224.64KB
CHM Resignation of CEO and Managing Director
01/05/24PRICE SENSITIVE download Created with Sketch. 170.33KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 1.55MB
CHM Change of Director's Interest Notice PH
08/04/24 download Created with Sketch. 170.14KB
CHM Change of Director's Interest Notice PH
08/04/24 download Created with Sketch. 211.99KB
CHM US patent allowed for CHM 0201 (CORE-NK) technology
05/04/24 download Created with Sketch. 172.62KB
CHM Notification of cessation of securities - CHM
02/04/24 download Created with Sketch. 12.78KB
CHM Notice under section 708A
28/03/24 download Created with Sketch. 202.53KB
CHM Application for quotation of securities - CHM
28/03/24 download Created with Sketch. 15.8KB
CHM Chimeric to present at NWR Virtual Healthcare Conference
15/03/24 download Created with Sketch. 171.83KB
CHM Clinical milestones for 2024 & 2023 successes highlighted
14/03/24PRICE SENSITIVE download Created with Sketch. 267.67KB
CHM Notification of cessation of securities - CHM
07/03/24 download Created with Sketch. 13.49KB
CHM Notice under section 708A
29/02/24 download Created with Sketch. 203.08KB
CHM Half Yearly Report and Accounts
29/02/24PRICE SENSITIVE download Created with Sketch. 1.87MB
CHM Application for quotation of securities - CHM
28/02/24 download Created with Sketch. 15.79KB
CHM Chimeric to present at ShareCafe Hidden Gems webinar
28/02/24 download Created with Sketch. 171.46KB
CHM Late lodgement of Appendix 3Y
15/02/24 download Created with Sketch. 333.3KB
CHM 1st patient treated in ADVENT-AML Phase 1b clinical trial
08/02/24PRICE SENSITIVE download Created with Sketch. 196.21KB
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 297.36KB
CHM Application for quotation of securities - CHM
24/01/24 download Created with Sketch. 24.77KB
CHM Investor Presentation
18/01/24 download Created with Sketch. 8.75MB
CHM Placement of Entitlement Offer Shortfall
18/01/24PRICE SENSITIVE download Created with Sketch. 200.57KB
CHM ADVENT-AML Phase 1B clinical trial open to enrolment
15/01/24PRICE SENSITIVE download Created with Sketch. 197KB
CHM CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVE
10/01/24PRICE SENSITIVE download Created with Sketch. 172.69KB
CHM Notice Under Section 708A
05/01/24 download Created with Sketch. 202.47KB
CHM Notification regarding unquoted securities - CHM
05/01/24 download Created with Sketch. 26.24KB
CHM Application for quotation of securities - CHM
05/01/24 download Created with Sketch. 25.43KB
CHM Proposed issue of securities - CHM
04/01/24 download Created with Sketch. 24.39KB
CHM Proposed issue of securities - CHM
04/01/24 download Created with Sketch. 24.44KB
CHM CHM Secures Further $1M Investment
04/01/24 download Created with Sketch. 196.74KB
CHM Notice under section 708A
22/12/23 download Created with Sketch. 202.39KB
CHM Application for quotation of securities - CHM
22/12/23 download Created with Sketch. 25.02KB
CHM Notification regarding unquoted securities - CHM
22/12/23 download Created with Sketch. 23.71KB
CHM Chimeric to present at Biotech Showcase at JPM week
21/12/23 download Created with Sketch. 172.96KB
CHM ADVENT-AML clinical trial GMP manufacturing complete
19/12/23 download Created with Sketch. 197.85KB
CHM Notice under section 708A
15/12/23 download Created with Sketch. 202.34KB
CHM Change of Director's Interest Notice JC
15/12/23 download Created with Sketch. 238.57KB
CHM Notification of cessation of securities - CHM
15/12/23 download Created with Sketch. 22.2KB
CHM Notification regarding unquoted securities - CHM
15/12/23 download Created with Sketch. 26.63KB
CHM Notification regarding unquoted securities - CHM
15/12/23 download Created with Sketch. 27.35KB
CHM Application for quotation of securities - CHM
15/12/23 download Created with Sketch. 33.85KB
CHM Change of Director's Interest Notice PHa
14/12/23 download Created with Sketch. 185.13KB
CHM Application for quotation of securities - CHM
07/12/23 download Created with Sketch. 24.93KB
CHM Completion of Entitlement Offer
07/12/23PRICE SENSITIVE download Created with Sketch. 167.31KB
CHM Positive in vitro data for CHM 1301 CAR NK cells-supplement
28/11/23 download Created with Sketch. 223.63KB
CHM Program update webinar with executive team - Tuesday 28 Nov
24/11/23 download Created with Sketch. 208.4KB
CHM Positive in vitro data for CHM 1301 CAR NK cells
23/11/23PRICE SENSITIVE download Created with Sketch. 217.9KB
CHM Amended Constitution
22/11/23 download Created with Sketch. 573.94KB
CHM Phase 1B ADVENT-AML trial to be presented at ASH meeting
20/11/23 download Created with Sketch. 219.57KB
CHM Update - Proposed issue of securities - CHM
15/11/23 download Created with Sketch. 28.27KB
CHM Entitlement Offer closing date extended to 30 November 2023
15/11/23 download Created with Sketch. 193.75KB
CHM Results of Annual General Meeting
14/11/23 download Created with Sketch. 228.67KB
CHM Presentation to Annual General Meeting
14/11/23 download Created with Sketch. 1.72MB
CHM Notice under section 708A
03/11/23 download Created with Sketch. 202KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.858K 619.3K

Buyers (Bids)

No. Vol. Price($)
66 58647032 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 107164382 32
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.